Top Markets
Coin of the day
Evgen Pharma plc Evgen Pharma plc

Evgen Pharma plc

EVG
Rang în acțiuni #38016
Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates... Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates at the clinical development stage, concentrating on the creation of sulforaphane-based medications. Its mission is to combat various cancers and inflammatory conditions. The firm utilizes its proprietary Sulforadex technology, which is engineered to stabilize sulforaphane, in its product development. SFX-01 stands as their principal drug candidate, currently in Phase II clinical trials for metastatic breast cancer and Phase Ib/IIa trials for glioblastoma. Furthermore, SFX-01 is being investigated in preclinical stages for haematological malignancies and analogous disorders. The company also offers out-licensing services for its innovative technology.
Preț acțiune
$0.00953895
Ultima sincronizare: 2024-05-22
Capitalizare de piață
$1.28M
Schimbare (1 zi)
0.06%
Schimbare (1 an)
0.00%
Țară
GB
Tranzacționează Evgen Pharma plc (EVG)

Categorie

Raport P/S pentru Evgen Pharma plc (EVG)
Raport P/S la data de 2026 TTM: 0
Conform celor mai recente rapoarte financiare și prețului acțiunilor Evgen Pharma plc, raportul P/S actual (TTM) este 0. La sfârșitul anului 2026, compania avea un P/S de 0.
Istoricul raportului P/S pentru Evgen Pharma plc din 2026 până în 2026
Raport P/S la sfârșitul fiecărui an
An Raport P/S Schimbă
Nu sunt suficiente date pentru perioada selectată.
Raport P/S pentru companii similare sau competitoare
Companie Raport P/S Diferență raport P/S Țara
9.88 -
US
10.30 -
NL
- -
CH
- -
KR
4.98 -
BE